| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| FOXA2 |
HUES64-derived endodermal cells |
|
Permissive
|
Homo sapiens |
GSE46130
...
|
MA0047.3
|
| FOXA2 |
Caco-2 (colon adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE66218
|
MA0047.3
|
| FOXA3 |
HepG2 (hepatoblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR092OVN
|
MA1683.1
|
| FOXD3 |
A549 (lung carcinoma) |
|
Permissive
|
Homo sapiens |
GSE93323
...
|
MA0041.1
|
| FOXE1 |
HeLa (cervical adenocarcinoma) |
|
Permissive
|
Homo sapiens |
GSE36185
...
|
MA1487.1
|
| FOXG1 |
cortex |
Develomental stage: embryonic day 14-15 Strain: CD1 |
Permissive
Robust
|
Mus musculus |
GSE96070
...
|
MA0613.1
|
| FOXG1 |
cortex |
Develomental stage: embryonic day 14-15 Strain: CD1 |
Permissive
Robust
|
Mus musculus |
GSE96070
...
|
MA0613.1
|
| FOXG1 |
intestinal villus epithelial cells |
Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed +/+, Villin-CRE (wildtype); Strain: B6;129 mixed background; |
Permissive
|
Mus musculus |
GSE111024
...
|
MA0613.1
|
| FOXG1 |
intestinal villus epithelial cells |
Day: 11; Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed F/F; Villin-CRE(Eed knockout); Strain: B6;129 mixed background; |
Permissive
|
Mus musculus |
GSE111024
...
|
MA0613.1
|
| FOXH1 |
4.5 hpf embryo |
none |
Permissive
Robust
|
Danio rerio |
GSE67648
...
|
MA0479.1
|
Showing 10 records in page 256
from 658 pages